Post by Moderna on X
Moderna@moderna_tx
XAlong with our partners at @Merck, we announced positive results from the Phase 3 INTerpath-001 study of intismeran autogene, our investigational individualized neoantigen therapy, in combination with pembrolizumab as adjuvant treatment in patients with completely resected Stage

639 likes0 repliesPosted Aug 19, 2026